Calyx Bio-Ventures Inc. (TSXV:CYX) announced a non-brokered private placement of 14,285,714 units at CAD 0.07 per unit for gross proceeds of CAD 1,000,000 on October 19, 2017. Each unit consists of one common share and one half of one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at a price of CAD 0.15 per share for a period of 24 months from the date of closing. The securities issued are subject to a hold period of four months plus one day from the date of closing. The transaction is subject to TSX Venture Exchange approval.